PROMOTE A HEALTHIER LIFE FOR HUMANKIND THROUGH ADVANCEMENTS IN SCIENCE.
BENEFIT THE PATIENTS WITH HIGH-QUALITY MEDICATION AS WE DETERMINED TO INNOVATE.
BUILD A LEADING GLOBAL BIOPHARMACEUTICAL GROUP TO SERVE MORE.
FULFILL SOCIAL RESPONSIBILITIES THROUGH ACCOUNTABLE ACTIONS.
新闻速递
AGGAMEHER2 ADC创新药瑞康曲妥珠单抗晚期实体瘤全球I期临床最终分析登上《自然》子刊STTT
焦点新闻
AGGAME医药合作伙伴Kailera Therapeutics公司成功在美国纳斯达克挂牌上市
创立于
全球员工
1类创新药
2类新药
SH 600276
HK 1276
关于我们
投资者关系
人才发展,了解更多